Literature DB >> 23450191

Severe Thrombocytopenia in an Immune Thrombocytopenic Parturient Non-responder to Medical Line of Treatment: Anaesthetic Management for Splenectomy Combined with Caesarean Section.

Vikas Karne1, Meenal Patil.   

Abstract

We report anaesthesia management of a parturient with severe thrombocytopenia secondary to immune thrombocytopenic purpura (ITP). Her platelet count remained around 3 × 10(9)/l in spite of optimum medical therapy and hence was posted for splenectomy combined with caesarean section. Anaesthesia implications of severe thrombocytopenia comprises risk of central nervous system bleeding, perioperative haemorrhage causing placental hypoperfusion and foetal hypoxia, risk of trauma to compromised airway and risk of epidural haematoma. The purpose of this paper is to discuss the risk factors associated, different management strategies and also to review the literature in an attempt to ameliorate the anaesthesiologist in perioperative management of these cases.

Entities:  

Keywords:  Anaesthesia; Caesarean section; Idiopathic purpura; Immune purpura; Non-responder; Splenectomy; Thrombocytopenia

Year:  2011        PMID: 23450191      PMCID: PMC3311964          DOI: 10.1007/s12288-011-0092-0

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  16 in total

Review 1.  Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults.

Authors:  Drew Provan; Adrian Newland
Journal:  Br J Haematol       Date:  2002-09       Impact factor: 6.998

2.  Regional anesthesia in parturients with low platelet counts.

Authors:  Vladmir Frenk; William Camann; Kodali Bhavani Shankar
Journal:  Can J Anaesth       Date:  2005-01       Impact factor: 5.063

3.  Diagnosis and treatment of idiopathic thrombocytopenic purpura: recommendations of the American Society of Hematology. The American Society of Hematology ITP Practice Guideline Panel.

Authors: 
Journal:  Ann Intern Med       Date:  1997-02-15       Impact factor: 25.391

Review 4.  Therapy for adults with refractory chronic immune thrombocytopenic purpura.

Authors:  R McMillan
Journal:  Ann Intern Med       Date:  1997-02-15       Impact factor: 25.391

Review 5.  The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.

Authors:  Cindy Neunert; Wendy Lim; Mark Crowther; Alan Cohen; Lawrence Solberg; Mark A Crowther
Journal:  Blood       Date:  2011-02-16       Impact factor: 22.113

6.  Safe epidural analgesia in thirty parturients with platelet counts between 69,000 and 98,000 mm(-3).

Authors:  Y Beilin; J Zahn; M Comerford
Journal:  Anesth Analg       Date:  1997-08       Impact factor: 5.108

Review 7.  Management of idiopathic thrombocytopenic purpura in pregnancy.

Authors:  K K Gill; J G Kelton
Journal:  Semin Hematol       Date:  2000-07       Impact factor: 3.851

8.  Moderate to severe thrombocytopenia during pregnancy.

Authors:  Michal Parnas; Eyal Sheiner; Ilana Shoham-Vardi; Eliezer Burstein; Tikva Yermiahu; Itai Levi; Gershon Holcberg; Ronit Yerushalmi
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2006-03-13       Impact factor: 2.435

Review 9.  Immune thrombocytopenic purpura in pregnancy.

Authors:  Terry Gernsheimer; Keith R McCrae
Journal:  Curr Opin Hematol       Date:  2007-09       Impact factor: 3.284

10.  Immune thrombocytopenic purpura during pregnancy: laparoscopic treatment.

Authors:  B V Anglin; C Rutherford; R Ramus; M Lieser; D B Jones
Journal:  JSLS       Date:  2001 Jan-Mar       Impact factor: 2.172

View more
  2 in total

1.  Splenectomy during pregnancy: treatment of refractory immune thrombocytopenic purpura.

Authors:  Reeta Mahey; Simran Deep Kaur; Sunil Chumber; Alka Kriplani; Neerja Bhatla
Journal:  BMJ Case Rep       Date:  2013-12-20

2.  Anaesthesia management in a patient with severe idiopathic thrombocytopaenia with antepartum haemorrhage for emergency caesarean section.

Authors:  Anjana Sagar Wajekar
Journal:  Indian J Anaesth       Date:  2015-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.